Morimoto Shinji, Tokano Yoshiaki, Nakano Souichiro, Watanabe Takashi, Tamayama Yoshihiro, Mitsuo Akiko, Suzuki Jun, Kaneko Hiroshi, Sekigawa Iwao, Takasaki Yoshinari
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
Autoimmunity. 2009 Feb;42(2):143-9. doi: 10.1080/08916930802438790.
Proliferative lupus nephritis (PLN) is the common, severe, and important form of lupus nephritis. Recent report showed that T cells producing Interferon (IFN)gamma (Th1 cells) increased in patients with World Health Organization class IV. However, the relation between the increase of Th1 cells and the pathogenesis has been made unclear. The aim of this study was to examine the chemoattractant mechanism of Th1-producing cells and whether in vitro IFNgamma secretion from Th1-producing cells in PLN. The Th1:Th2 ratio in peripheral blood was measured by flow cytometry. The serum levels of IL-2, IFNgamma, IL-13, monocyte chemoattractant protein-1 (MCP-1) and IP-10 were determined by using enzyme-linked immunosorbent assay. In in vitro IFNgamma production assay, CD4(+)T cells co-cultured with IL-12 and/or IL-18. Th1:Th2 ratio in PLN was high and not correlated with the serum Th1 cytokine level. This Th1-producing cell tended to go toward the inflammatory lesion by low CD62L expression and chemokines. The level of MCP-1 and IP-10 in patients with PLN significantly increased. Lastly, in vitro IFNgamma production assay, patients with PLN CD4(+)T cells produced IFNgamma by the addition of IL-12 and IL-18, while CD4(+)T cells in normal controls did not produce. These findings suggest that combination of Th1 inducers and chemokine inhibition might be powerful threrapeutic approach in PLN.
增殖性狼疮性肾炎(PLN)是狼疮性肾炎常见、严重且重要的一种形式。最近的报告显示,世界卫生组织IV级患者中产生干扰素(IFN)γ的T细胞(Th1细胞)增加。然而,Th1细胞增加与发病机制之间的关系尚不清楚。本研究的目的是研究Th1产生细胞的趋化机制以及PLN中Th1产生细胞体外IFNγ分泌情况。通过流式细胞术检测外周血中Th1:Th2比值。采用酶联免疫吸附测定法测定血清白细胞介素-2(IL-2)、IFNγ、IL-13、单核细胞趋化蛋白-1(MCP-1)和干扰素诱导蛋白10(IP-10)水平。在体外IFNγ产生试验中,将CD4(+)T细胞与IL-12和/或IL-18共培养。PLN中的Th1:Th2比值较高,且与血清Th1细胞因子水平无关。这种Th1产生细胞因低表达CD62L和趋化因子而倾向于向炎症病变部位移动。PLN患者的MCP-1和IP-10水平显著升高。最后,在体外IFNγ产生试验中,PLN患者的CD4(+)T细胞在添加IL-12和IL-18后产生IFNγ,而正常对照中的CD4(+)T细胞则不产生。这些发现表明,Th1诱导剂与趋化因子抑制相结合可能是PLN强有力的治疗方法。